EDOXABAN TOSYLATE

EDOXABAN TOSYLATE was reported 6825 times

EDOXABAN TOSYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FEMORAL HERNIA INCARCERATED 28 0.3889
1 LYMPHATIC FISTULA 28 0.2800
2 HEPARIN RESISTANCE 16 0.1311
3 PANCREATIC STEATOSIS 27 0.0993
4 NAIL BED INFLAMMATION 30 0.0940
5 WOUND INFECTION PSEUDOMONAS 28 0.0895
6 SUSPECTED DRUG-INDUCED LIVER INJURY 12 0.0600
7 ANTICOAGULANT-RELATED NEPHROPATHY 9 0.0570
8 SMALL INTESTINE POLYP 4 0.0488
9 IMMOBILISATION SYNDROME 10 0.0469
10 NASAL MUCOSAL DISORDER 27 0.0463
11 THROMBOPHLEBITIS MIGRANS 15 0.0441
12 GASTROINTESTINAL ANGIECTASIA 4 0.0339
13 STREPTOCOCCAL SEPSIS 40 0.0337
14 SACROILIAC JOINT DYSFUNCTION 4 0.0301
15 ORCHITIS NONINFECTIVE 5 0.0292
16 PUTAMEN HAEMORRHAGE 8 0.0281
17 ARTERIAL HAEMORRHAGE 31 0.0271
18 PSEUDARTHROSIS 6 0.0262
19 EMBOLIC STROKE 79 0.0224
20 PSEUDOMONAL SEPSIS 38 0.0217
21 AORTIC VALVE STENOSIS 38 0.0213
22 SEROMA 27 0.0212
23 HYPERINSULINAEMIC HYPOGLYCAEMIA 4 0.0180
24 STOMA OBSTRUCTION 4 0.0175
25 EMBOLIC CEREBRAL INFARCTION 11 0.0166
26 MACULAR DETACHMENT 4 0.0165
27 GASTROINTESTINAL ANGIODYSPLASIA 6 0.0146
28 PYOGENIC GRANULOMA 6 0.0129
29 TONGUE SPASM 4 0.0128
30 HAEMORRHAGIC INFARCTION 7 0.0128
31 BALANOPOSTHITIS 10 0.0122
32 CHOLANGITIS ACUTE 9 0.0119
33 CARDIAC FAILURE CHRONIC 49 0.0115
34 FAECAL OCCULT BLOOD POSITIVE 4 0.0114
35 CEREBRAL INFARCTION 273 0.0112
36 THROMBOTIC CEREBRAL INFARCTION 4 0.0106
37 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 7 0.0106
38 CARDIAC FAILURE ACUTE 69 0.0103
39 CEREBRAL ARTERY OCCLUSION 11 0.0103
40 CEREBELLAR STROKE 4 0.0102
41 THALAMIC INFARCTION 6 0.0101
42 TACHYARRHYTHMIA 25 0.0100
43 CEREBRAL ARTERY EMBOLISM 12 0.0098
44 HEPATIC CYST 33 0.0097
45 AORTIC OCCLUSION 4 0.0097
46 AORTIC ARTERIOSCLEROSIS 25 0.0097
47 HAEMOBILIA 4 0.0096
48 LEFT ATRIAL ENLARGEMENT 5 0.0093
49 MYCOPLASMA INFECTION 7 0.0090
50 CREATININE RENAL CLEARANCE ABNORMAL 4 0.0086
51 VARICOSE VEIN 44 0.0085
52 DIVERTICULUM INTESTINAL 37 0.0085
53 CARDIAC AMYLOIDOSIS 9 0.0082
54 VASCULAR DEVICE INFECTION 37 0.0081
55 PHIMOSIS 6 0.0081
56 IMMUNE-MEDIATED THYROIDITIS 4 0.0081
57 THALAMUS HAEMORRHAGE 7 0.0080
58 WOUND DEHISCENCE 27 0.0080
59 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 5 0.0078
60 RUPTURED CEREBRAL ANEURYSM 5 0.0077
61 ORTHOPAEDIC PROCEDURE 4 0.0077
62 GASTRIC ANTRAL VASCULAR ECTASIA 4 0.0076
63 HAEMATOMA MUSCLE 9 0.0075
64 HEAT ILLNESS 5 0.0074
65 KLEBSIELLA BACTERAEMIA 7 0.0074
66 LEUKOCYTURIA 6 0.0073
67 BRAIN NATRIURETIC PEPTIDE INCREASED 22 0.0071
68 COAGULATION TIME PROLONGED 11 0.0071
69 HAEMORRHAGE SUBCUTANEOUS 25 0.0070
70 PRINZMETAL ANGINA 7 0.0070
71 MESENTERIC VEIN THROMBOSIS 7 0.0070
72 ORTHOSTATIC INTOLERANCE 5 0.0070
73 IMMUNE-MEDIATED DERMATITIS 7 0.0069
74 PRODUCT MONITORING ERROR 10 0.0069
75 RENAL INFARCT 10 0.0069
76 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 6 0.0068
77 PARONYCHIA 30 0.0068
78 SPINAL EPIDURAL HAEMATOMA 4 0.0068
79 EMBOLISM ARTERIAL 8 0.0067
80 BLEEDING TIME PROLONGED 8 0.0066
81 GASTROINTESTINAL POLYP HAEMORRHAGE 4 0.0066
82 MARASMUS 10 0.0066
83 SINUS NODE DYSFUNCTION 12 0.0065
84 ANEURYSM RUPTURED 6 0.0065
85 MUSCLE ABSCESS 4 0.0064
86 PRERENAL FAILURE 9 0.0064
87 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 5 0.0063
88 ACTIVITIES OF DAILY LIVING DECREASED 4 0.0063
89 PHYSICAL DECONDITIONING 16 0.0062
90 FAECALOMA 34 0.0062
91 IMMUNE-MEDIATED MYOCARDITIS 10 0.0062
92 PENILE HAEMORRHAGE 5 0.0061
93 CHONDROCALCINOSIS 4 0.0061
94 SPUTUM RETENTION 6 0.0061
95 CEREBELLAR INFARCTION 10 0.0059
96 SHOCK HAEMORRHAGIC 48 0.0059
97 FULMINANT TYPE 1 DIABETES MELLITUS 6 0.0058
98 VENOUS THROMBOSIS LIMB 12 0.0058
99 TRICUSPID VALVE INCOMPETENCE 46 0.0058
100 DIVERTICULUM INTESTINAL HAEMORRHAGIC 13 0.0058
101 DYSLALIA 4 0.0055
102 SYPHILIS 4 0.0055
103 METASTASES TO LYMPH NODES 37 0.0055
104 INFLAMMATORY MARKER INCREASED 27 0.0054
105 APLASTIC ANAEMIA 28 0.0054
106 ARTERIAL INJURY 4 0.0054
107 IMMUNE-MEDIATED HYPOTHYROIDISM 6 0.0053
108 AORTIC DISSECTION 22 0.0053
109 MALIGNANT ASCITES 4 0.0052
110 STOMA SITE HAEMORRHAGE 8 0.0052
111 CARDIAC ABLATION 9 0.0050
112 ESCHERICHIA TEST POSITIVE 6 0.0050
113 PERIPHERAL ARTERY OCCLUSION 7 0.0050
114 CEREBELLAR HAEMORRHAGE 7 0.0049
115 ATRIAL THROMBOSIS 10 0.0048
116 SUPERFICIAL VEIN THROMBOSIS 4 0.0048
117 POSTOPERATIVE WOUND INFECTION 32 0.0047
118 SUBCUTANEOUS HAEMATOMA 6 0.0047
119 MITRAL VALVE INCOMPETENCE 53 0.0047
120 FEMORAL NECK FRACTURE 24 0.0047
121 GROIN PAIN 41 0.0047
122 GINGIVAL ERYTHEMA 4 0.0046
123 RETROPERITONEAL HAEMATOMA 10 0.0045
124 MELAENA 99 0.0045
125 HAEMATURIA 154 0.0045
126 CYTOMEGALOVIRUS TEST POSITIVE 8 0.0045
127 LEFT VENTRICULAR DYSFUNCTION 30 0.0045
128 EAR HAEMORRHAGE 9 0.0044
129 TRAUMATIC INTRACRANIAL HAEMORRHAGE 4 0.0044
130 CARDIOVERSION 6 0.0043
131 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0043
132 BLOOD URINE 4 0.0041
133 HAEMOTHORAX 12 0.0041
134 HENOCH-SCHONLEIN PURPURA 9 0.0041
135 BACTERIAL TEST POSITIVE 9 0.0040
136 HELICOBACTER GASTRITIS 5 0.0040
137 CHOLANGIOCARCINOMA 6 0.0040
138 EMPYEMA 8 0.0040
139 SPLENIC INFARCTION 7 0.0040
140 SMALL INTESTINAL HAEMORRHAGE 8 0.0040
141 BRAIN STEM INFARCTION 4 0.0039
142 HAEMARTHROSIS 35 0.0039
143 HAEMORRHOIDAL HAEMORRHAGE 19 0.0039
144 ESCHERICHIA INFECTION 32 0.0039
145 CHOLANGITIS 24 0.0039
146 STRESS URINARY INCONTINENCE 4 0.0037
147 PULMONARY TOXICITY 26 0.0037
148 THYROIDITIS 11 0.0037
149 HAEMORRHAGIC DIATHESIS 13 0.0036
150 BRADYARRHYTHMIA 6 0.0036
151 PARESIS 8 0.0036
152 CARDIAC TAMPONADE 17 0.0036
153 LARGE INTESTINAL HAEMORRHAGE 8 0.0036
154 SUBCLAVIAN VEIN THROMBOSIS 4 0.0035
155 RENAL IMPAIRMENT 295 0.0035
156 LABELLED DRUG-DRUG INTERACTION ISSUE 5 0.0035
157 PAROTITIS 4 0.0034
158 ISCHAEMIC CEREBRAL INFARCTION 4 0.0034
159 SENSE OF OPPRESSION 4 0.0034
160 CARDIAC FAILURE 270 0.0034
161 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 4 0.0033
162 UPPER RESPIRATORY TRACT INFLAMMATION 4 0.0033
163 BRAIN OEDEMA 42 0.0033
164 ATRIOVENTRICULAR BLOCK COMPLETE 22 0.0033
165 PANCREATIC NEOPLASM 4 0.0032
166 CARDIAC DYSFUNCTION 12 0.0032
167 PROTHROMBIN TIME PROLONGED 19 0.0032
168 GLOMERULAR FILTRATION RATE DECREASED 39 0.0032
169 LEFT ATRIAL DILATATION 4 0.0031
170 RHEUMATIC DISORDER 6 0.0031
171 CONCOMITANT DISEASE PROGRESSION 6 0.0031
172 PNEUMONIA ASPIRATION 76 0.0030
173 EXTRADURAL HAEMATOMA 4 0.0030
174 ANURIA 26 0.0030
175 IGA NEPHROPATHY 5 0.0030
176 QUADRIPARESIS 5 0.0030
177 CREATININE RENAL CLEARANCE DECREASED 12 0.0030
178 HYPOPHYSITIS 6 0.0030
179 ATRIOVENTRICULAR BLOCK 23 0.0030
180 INTRA-ABDOMINAL HAEMORRHAGE 7 0.0029
181 IMMUNE-MEDIATED HEPATITIS 6 0.0029
182 HYPERURICAEMIA 12 0.0029
183 UPPER GASTROINTESTINAL HAEMORRHAGE 49 0.0029
184 SUBILEUS 6 0.0029
185 VASCULAR PSEUDOANEURYSM 5 0.0029
186 SUBDURAL HAEMATOMA 41 0.0029
187 PERIPHERAL ARTERY THROMBOSIS 4 0.0028
188 JOINT DISLOCATION 30 0.0028
189 FIBRIN D DIMER INCREASED 10 0.0028
190 SUBARACHNOID HAEMORRHAGE 28 0.0027
191 PULMONARY VALVE INCOMPETENCE 4 0.0027
192 CEREBRAL ISCHAEMIA 14 0.0027
193 WOUND HAEMORRHAGE 10 0.0027
194 METASTASES TO CENTRAL NERVOUS SYSTEM 34 0.0026
195 HYPOPROTEINAEMIA 5 0.0026
196 ATRIAL FLUTTER 21 0.0026
197 CEREBRAL HAEMORRHAGE 94 0.0026
198 PNEUMONIA BACTERIAL 24 0.0026
199 PULMONARY HYPERTENSION 54 0.0026
200 DIASTOLIC DYSFUNCTION 8 0.0026
201 PNEUMONIA CYTOMEGALOVIRAL 5 0.0026
202 LOWER GASTROINTESTINAL HAEMORRHAGE 19 0.0026
203 IMMUNE-MEDIATED HEPATIC DISORDER 5 0.0026
204 NON-SMALL CELL LUNG CANCER 12 0.0025
205 INTERSTITIAL LUNG DISEASE 121 0.0025
206 METABOLIC ALKALOSIS 4 0.0025
207 IRON DEFICIENCY ANAEMIA 23 0.0025
208 GASTROINTESTINAL HAEMORRHAGE 207 0.0025
209 VENTRICULAR ARRHYTHMIA 9 0.0025
210 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 5 0.0024
211 MYELODYSPLASTIC SYNDROME 35 0.0024
212 CONTRAINDICATED PRODUCT PRESCRIBED 4 0.0024
213 ATRIAL TACHYCARDIA 5 0.0024
214 NEPHROGENIC ANAEMIA 11 0.0024
215 MALIGNANT PLEURAL EFFUSION 4 0.0024
216 ESCHERICHIA URINARY TRACT INFECTION 10 0.0024
217 ATRIAL FIBRILLATION 226 0.0023
218 MOUTH HAEMORRHAGE 17 0.0023
219 PULMONARY ALVEOLAR HAEMORRHAGE 13 0.0023
220 HYPOALBUMINAEMIA 18 0.0023
221 CRANIOCEREBRAL INJURY 7 0.0023
222 HYPOPITUITARISM 4 0.0023
223 AORTIC STENOSIS 8 0.0023
224 CHOLECYSTITIS ACUTE 13 0.0023
225 HIATUS HERNIA 29 0.0022
226 CARDIOGENIC SHOCK 32 0.0022
227 PYODERMA GANGRENOSUM 8 0.0022
228 PRESYNCOPE 54 0.0022
229 BLOOD LOSS ANAEMIA 5 0.0022
230 IMMUNE-MEDIATED LUNG DISEASE 4 0.0022
231 CAROTID ARTERY OCCLUSION 8 0.0022
232 IMMUNE-MEDIATED ENTEROCOLITIS 8 0.0022
233 VITREOUS HAEMORRHAGE 6 0.0022
234 GASTRITIS EROSIVE 10 0.0021
235 ISCHAEMIC STROKE 38 0.0021
236 CORONAVIRUS INFECTION 14 0.0021
237 AORTIC VALVE INCOMPETENCE 9 0.0021
238 CARDIOMEGALY 26 0.0021
239 VOLVULUS 5 0.0021
240 HYPERCOAGULATION 4 0.0021
241 PANCREATIC CYST 4 0.0021
242 RETINAL OEDEMA 4 0.0021
243 LACUNAR INFARCTION 5 0.0021
244 CANDIDA INFECTION 35 0.0021
245 BRAIN HERNIATION 6 0.0020
246 POLYNEUROPATHY 24 0.0020
247 CAROTID ARTERY STENOSIS 7 0.0020
248 LUNG ADENOCARCINOMA 6 0.0020
249 PEMPHIGOID 15 0.0020
250 ON AND OFF PHENOMENON 11 0.0020
251 METASTASES TO PERITONEUM 5 0.0020
252 URINARY TRACT INFECTION BACTERIAL 5 0.0020
253 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 10 0.0020
254 RENAL HAEMORRHAGE 4 0.0020
255 RECTAL CANCER 6 0.0020
256 ENDOCARDITIS 10 0.0019
257 ARTHRITIS BACTERIAL 8 0.0019
258 FAECES DISCOLOURED 42 0.0019
259 EMBOLISM 16 0.0019
260 HYPOVOLAEMIC SHOCK 9 0.0019
261 CATHETER SITE ERYTHEMA 4 0.0019
262 SKIN EROSION 6 0.0019
263 HAEMATOMA 48 0.0019
264 OSTEOPENIA 28 0.0018
265 GINGIVAL BLEEDING 25 0.0018
266 TYPE IV HYPERSENSITIVITY REACTION 5 0.0018
267 COLONOSCOPY 4 0.0018
268 IMMUNE-MEDIATED MYOSITIS 5 0.0018
269 C-REACTIVE PROTEIN INCREASED 66 0.0018
270 RED BLOOD CELL COUNT INCREASED 5 0.0018
271 SOPOR 24 0.0018
272 POST PROCEDURAL HAEMORRHAGE 21 0.0018
273 RASH MORBILLIFORM 5 0.0018
274 PLANTAR FASCIITIS 6 0.0018
275 TORSADE DE POINTES 14 0.0018
276 IRON DEFICIENCY 8 0.0018
277 CHRONIC GASTRITIS 4 0.0018
278 HYPOPHOSPHATAEMIA 13 0.0018
279 DUODENAL ULCER HAEMORRHAGE 5 0.0017
280 IMMUNE THROMBOCYTOPENIA 8 0.0017
281 ANAEMIA 329 0.0017
282 GASTROINTESTINAL NECROSIS 5 0.0017
283 THROMBOPHLEBITIS 6 0.0017
284 EPISTAXIS 128 0.0017
285 DISSEMINATED INTRAVASCULAR COAGULATION 24 0.0017
286 DRUG ERUPTION 30 0.0017
287 SKIN FISSURES 33 0.0017
288 HEMIPLEGIA 14 0.0017
289 COMPRESSION FRACTURE 9 0.0017
290 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
291 HEPATIC FUNCTION ABNORMAL 62 0.0017
292 ERUCTATION 32 0.0017
293 HYDROCEPHALUS 9 0.0017
294 EMBOLISM VENOUS 5 0.0016
295 DYSAESTHESIA 5 0.0016
296 GASTRIC ULCER HAEMORRHAGE 9 0.0016
297 STAPHYLOCOCCAL SEPSIS 8 0.0016
298 CONCOMITANT DISEASE AGGRAVATED 10 0.0016
299 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
300 ALTERED STATE OF CONSCIOUSNESS 35 0.0016
301 NEPHROTIC SYNDROME 11 0.0016
302 CORONARY ARTERY STENOSIS 8 0.0016
303 RETINAL ARTERY OCCLUSION 4 0.0016
304 HAEMODYNAMIC INSTABILITY 12 0.0016
305 HAEMORRHAGE URINARY TRACT 4 0.0016
306 BILE DUCT STONE 5 0.0016
307 CANCER PAIN 4 0.0016
308 GASTRIC HAEMORRHAGE 18 0.0016
309 HYPONATRAEMIA 88 0.0016
310 PLEURAL EFFUSION 95 0.0016
311 BENIGN PROSTATIC HYPERPLASIA 8 0.0015
312 PORTAL VEIN THROMBOSIS 5 0.0015
313 ACTINIC KERATOSIS 4 0.0015
314 HAEMOGLOBIN INCREASED 7 0.0015
315 VENTRICULAR FIBRILLATION 17 0.0015
316 LISTLESS 5 0.0015
317 FAECES SOFT 11 0.0015
318 SUDDEN DEATH 16 0.0015
319 CARDIAC PACEMAKER INSERTION 9 0.0015
320 RENAL FUNCTION TEST ABNORMAL 7 0.0015
321 PERFORMANCE STATUS DECREASED 7 0.0015
322 CYSTITIS HAEMORRHAGIC 6 0.0015
323 BLOOD SODIUM INCREASED 4 0.0015
324 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 6 0.0015
325 CARDIOVASCULAR DISORDER 37 0.0015
326 SPINAL COMPRESSION FRACTURE 12 0.0014
327 RECTAL HAEMORRHAGE 62 0.0014
328 TRANSFUSION 15 0.0014
329 ANAL HAEMORRHAGE 4 0.0014
330 BLOOD URINE PRESENT 27 0.0014
331 HYPERNATRAEMIA 7 0.0014
332 TUMOUR HAEMORRHAGE 4 0.0014
333 HYPERKALAEMIA 49 0.0014
334 MYOCARDITIS 16 0.0014
335 ENTEROCOLITIS 8 0.0014
336 DYSPNOEA AT REST 4 0.0014
337 LUMBAR SPINAL STENOSIS 4 0.0014
338 PULMONARY CONGESTION 18 0.0014
339 WALKING AID USER 9 0.0014
340 HAEMOPTYSIS 38 0.0014
341 ACUTE CORONARY SYNDROME 11 0.0013
342 HEPATOCELLULAR CARCINOMA 10 0.0013
343 METASTASES TO LIVER 23 0.0013
344 ACUTE KIDNEY INJURY 200 0.0013
345 PRESCRIBED UNDERDOSE 26 0.0013
346 LARGE INTESTINE POLYP 9 0.0013
347 OLIGURIA 8 0.0013
348 URINARY RETENTION 43 0.0013
349 FAECES HARD 5 0.0013
350 RESTLESSNESS 47 0.0013
351 PROCEDURAL HAEMORRHAGE 5 0.0013
352 TOOTH ABSCESS 13 0.0013
353 DUODENAL ULCER 9 0.0013
354 INTESTINAL ISCHAEMIA 7 0.0013
355 ARRHYTHMIA 60 0.0013
356 BLOOD LACTATE DEHYDROGENASE INCREASED 20 0.0013
357 GENERAL PHYSICAL HEALTH DETERIORATION 146 0.0013
358 IMPAIRED HEALING 41 0.0012
359 HUMERUS FRACTURE 6 0.0012
360 HEMIPARESIS 21 0.0012
361 ADRENAL INSUFFICIENCY 15 0.0012
362 LIVER ABSCESS 4 0.0012
363 ANGINA UNSTABLE 8 0.0012
364 BLOOD SODIUM DECREASED 23 0.0012
365 HAEMATOCHEZIA 67 0.0012
366 BLOOD URIC ACID INCREASED 7 0.0012
367 DRUG-INDUCED LIVER INJURY 38 0.0012
368 EUGLYCAEMIC DIABETIC KETOACIDOSIS 5 0.0012
369 ORGANISING PNEUMONIA 6 0.0012
370 STRESS CARDIOMYOPATHY 7 0.0012
371 NEUTROPHIL COUNT DECREASED 49 0.0012
372 DERMATITIS ALLERGIC 15 0.0012
373 UROSEPSIS 11 0.0012
374 CEREBRAL HAEMATOMA 4 0.0012
375 BLOOD PRESSURE DECREASED 79 0.0012
376 CORONARY ARTERY DISEASE 36 0.0012
377 HALLUCINATIONS, MIXED 5 0.0012
378 ACUTE MYOCARDIAL INFARCTION 35 0.0012
379 BRADYKINESIA 7 0.0012
380 TONGUE ULCERATION 4 0.0012
381 TOE AMPUTATION 6 0.0012
382 BACTERAEMIA 14 0.0012
383 CHOLECYSTITIS 14 0.0012
384 FLANK PAIN 11 0.0012
385 PULMONARY ARTERIAL HYPERTENSION 17 0.0012
386 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
387 DIFFUSE LARGE B-CELL LYMPHOMA 9 0.0012
388 INTERNATIONAL NORMALISED RATIO ABNORMAL 4 0.0012
389 LEFT VENTRICULAR FAILURE 4 0.0012
390 GASTRIC ULCER 22 0.0012
391 ASCITES 34 0.0012
392 BLOOD CREATININE ABNORMAL 4 0.0012
393 PYELONEPHRITIS 10 0.0012
394 DERMATITIS ACNEIFORM 7 0.0011
395 BRADYCARDIA 61 0.0011
396 URINE OUTPUT DECREASED 10 0.0011
397 COLON CANCER 17 0.0011
398 HAEMORRHAGE INTRACRANIAL 17 0.0011
399 RENAL CYST 9 0.0011
400 JAUNDICE CHOLESTATIC 4 0.0011
401 CONJUNCTIVAL HYPERAEMIA 4 0.0011
402 TUBULOINTERSTITIAL NEPHRITIS 21 0.0011
403 CIRCULATORY COLLAPSE 19 0.0011
404 HYPOKALAEMIA 51 0.0011
405 DEVICE RELATED INFECTION 17 0.0011
406 MULTIPLE ORGAN DYSFUNCTION SYNDROME 31 0.0011
407 ENTERITIS 7 0.0011
408 ORAL DISORDER 8 0.0011
409 LUMBAR VERTEBRAL FRACTURE 5 0.0011
410 FEBRILE NEUTROPENIA 72 0.0011
411 HEART RATE ABNORMAL 6 0.0011
412 BRADYPHRENIA 7 0.0011
413 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 11 0.0011
414 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
415 AORTIC ANEURYSM 8 0.0011
416 INTERNAL HAEMORRHAGE 12 0.0010
417 CYTOKINE RELEASE SYNDROME 21 0.0010
418 INCONTINENCE 11 0.0010
419 GINGIVAL DISORDER 4 0.0010
420 OESOPHAGEAL ULCER 4 0.0010
421 METASTASES TO BONE 17 0.0010
422 DYSPNOEA EXERTIONAL 39 0.0010
423 SINUS BRADYCARDIA 10 0.0010
424 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 24 0.0010
425 ECCHYMOSIS 7 0.0010
426 LYMPHOCYTE COUNT DECREASED 18 0.0010
427 INTERNATIONAL NORMALISED RATIO INCREASED 29 0.0010
428 IDIOPATHIC PULMONARY FIBROSIS 4 0.0010
429 MUCOUS STOOLS 5 0.0010
430 OEDEMA PERIPHERAL 123 0.0010
431 HYPERTRANSAMINASAEMIA 7 0.0010
432 DEHYDRATION 134 0.0010
433 AZOTAEMIA 4 0.0010
434 HYPERAMMONAEMIA 5 0.0010
435 DERMATITIS EXFOLIATIVE 5 0.0010
436 RIGHT VENTRICULAR FAILURE 7 0.0010
437 MUSCLE HAEMORRHAGE 4 0.0010
438 INTRACRANIAL ANEURYSM 4 0.0010
439 TOXIC SKIN ERUPTION 10 0.0010
440 HYPERTENSIVE CRISIS 11 0.0010
441 HAEMATEMESIS 25 0.0010
442 TENSION 6 0.0010
443 DYSLIPIDAEMIA 5 0.0010
444 BLOOD CREATININE INCREASED 64 0.0010
445 PHLEBITIS 5 0.0010
446 HAEMORRHAGE 102 0.0010
447 EXTRAVASATION 4 0.0010
448 SYNCOPE 96 0.0010
449 FULL BLOOD COUNT ABNORMAL 10 0.0009
450 HYPOTHYROIDISM 30 0.0009
451 BLOOD CREATINE PHOSPHOKINASE INCREASED 27 0.0009
452 COVID-19 PNEUMONIA 11 0.0009
453 DRUG INTERACTION 147 0.0009
454 SEPTIC SHOCK 40 0.0009
455 POLYP 6 0.0009
456 AGRANULOCYTOSIS 17 0.0009
457 ANGINA PECTORIS 26 0.0009
458 PROSTATIC DISORDER 5 0.0009
459 PURPURA 8 0.0009
460 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
461 PELVIC FRACTURE 7 0.0009
462 HYPOCALCAEMIA 17 0.0009
463 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
464 MYOSITIS 8 0.0009
465 GASTROENTERITIS 13 0.0009
466 COLITIS ISCHAEMIC 6 0.0009
467 TRANSIENT ISCHAEMIC ATTACK 30 0.0009
468 ECZEMA 46 0.0009
469 ACUTE HEPATIC FAILURE 12 0.0009
470 RED BLOOD CELL COUNT DECREASED 25 0.0009
471 HYPERBILIRUBINAEMIA 9 0.0009
472 MYASTHENIA GRAVIS 7 0.0009
473 TOXIC EPIDERMAL NECROLYSIS 13 0.0009
474 PAPULE 6 0.0009
475 URINE ODOUR ABNORMAL 5 0.0008
476 PNEUMONITIS 23 0.0008
477 PROTEINURIA 16 0.0008
478 EJECTION FRACTION DECREASED 13 0.0008
479 BASAL CELL CARCINOMA 13 0.0008
480 DIZZINESS POSTURAL 8 0.0008
481 PANCYTOPENIA 46 0.0008
482 INGUINAL HERNIA 5 0.0008
483 HAEMORRHOIDS 16 0.0008
484 DEEP VEIN THROMBOSIS 53 0.0008
485 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
486 SKIN HAEMORRHAGE 12 0.0008
487 OSTEONECROSIS OF JAW 20 0.0008
488 THROMBOSIS 65 0.0008
489 ILEUS 10 0.0008
490 ANEURYSM 4 0.0008
491 ERYSIPELAS 4 0.0008
492 APHASIA 24 0.0008
493 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
494 PHOTOPSIA 5 0.0008
495 TOXIC ENCEPHALOPATHY 4 0.0008
496 HAEMOGLOBIN DECREASED 81 0.0008
497 COAGULOPATHY 13 0.0008
498 HEAVY MENSTRUAL BLEEDING 7 0.0008
499 RIB FRACTURE 16 0.0008
500 HAEMOGLOBIN ABNORMAL 5 0.0008
501 BLOOD UREA INCREASED 13 0.0008
502 PLATELET COUNT DECREASED 82 0.0008
503 ARTERIAL OCCLUSIVE DISEASE 6 0.0008
504 PRODUCT PRESCRIBING ERROR 18 0.0008
505 CEREBROVASCULAR ACCIDENT 128 0.0008
506 DECREASED APPETITE 175 0.0008
507 ERYTHEMA MULTIFORME 7 0.0007
508 HEPATIC ENCEPHALOPATHY 7 0.0007
509 GASTRIC CANCER 19 0.0007
510 EYE HAEMORRHAGE 10 0.0007
511 BLOOD DISORDER 6 0.0007
512 HEPATIC CIRRHOSIS 14 0.0007
513 PRODUCT RESIDUE PRESENT 4 0.0007
514 HIP SURGERY 4 0.0007
515 ASPARTATE AMINOTRANSFERASE INCREASED 39 0.0007
516 JOINT EFFUSION 5 0.0007
517 PRESCRIBED OVERDOSE 14 0.0007
518 LYMPHOEDEMA 5 0.0007
519 HYPOTENSION 145 0.0007
520 LIVER DISORDER 32 0.0007
521 DELIRIUM 25 0.0007
522 HYPOMAGNESAEMIA 10 0.0007
523 DEFAECATION URGENCY 5 0.0007
524 HAEMATOCRIT DECREASED 14 0.0007
525 LOSS OF CONSCIOUSNESS 90 0.0007
526 PSEUDOMONAS INFECTION 6 0.0007
527 RESPIRATORY FAILURE 51 0.0007
528 BACTERIAL INFECTION 13 0.0007
529 MYOPATHY 6 0.0007
530 PNEUMOTHORAX 11 0.0007
531 PANIC REACTION 5 0.0007
532 PNEUMONIA 224 0.0007
533 TASTE DISORDER 14 0.0007
534 VERTIGO 42 0.0007
535 VASCULITIS 8 0.0007
536 ORAL CANDIDIASIS 9 0.0007
537 OEDEMA 37 0.0007
538 MALIGNANT NEOPLASM PROGRESSION 69 0.0007
539 SUNBURN 5 0.0007
540 HAEMOLYTIC ANAEMIA 6 0.0007
541 LOSS OF LIBIDO 6 0.0007
542 VENTRICULAR TACHYCARDIA 11 0.0007
543 TYPE 1 DIABETES MELLITUS 4 0.0007
544 PALLOR 18 0.0007
545 OSTEOARTHRITIS 28 0.0007
546 STOMATITIS 40 0.0007
547 PERIPHERAL COLDNESS 9 0.0007
548 CONTUSION 63 0.0007
549 BREAST CANCER METASTATIC 7 0.0007
550 OVARIAN CANCER 6 0.0007
551 PERICARDIAL EFFUSION 15 0.0006
552 PIGMENTATION DISORDER 4 0.0006
553 FEMUR FRACTURE 20 0.0006
554 FALL 214 0.0006
555 APNOEA 5 0.0006
556 HAEMORRHAGIC STROKE 5 0.0006
557 DEVICE OCCLUSION 9 0.0006
558 UNDERDOSE 46 0.0006
559 STEVENS-JOHNSON SYNDROME 14 0.0006
560 HYPERTHYROIDISM 9 0.0006
561 PULMONARY EMBOLISM 59 0.0006
562 STENT PLACEMENT 5 0.0006
563 SEPSIS 69 0.0006
564 BLOOD POTASSIUM INCREASED 10 0.0006
565 HEPATITIS ACUTE 4 0.0006
566 GASTRITIS 16 0.0006
567 ELECTROLYTE IMBALANCE 7 0.0006
568 LEUKOPENIA 30 0.0006
569 QUALITY OF LIFE DECREASED 8 0.0006
570 EMPHYSEMA 6 0.0006
571 BLINDNESS 24 0.0006
572 EYE MOVEMENT DISORDER 4 0.0006
573 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
574 CARDIAC OPERATION 5 0.0006
575 VENTRICULAR EXTRASYSTOLES 6 0.0006
576 NOCTURIA 7 0.0006
577 SLEEP APNOEA SYNDROME 11 0.0006
578 SCHIZOPHRENIA 7 0.0006
579 POLLAKIURIA 24 0.0006
580 CARDIAC FAILURE CONGESTIVE 46 0.0006
581 SKIN DISORDER 19 0.0006
582 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
583 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
584 GENERALISED OEDEMA 7 0.0006
585 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
586 RENAL FAILURE 75 0.0006
587 DIVERTICULUM 4 0.0006
588 BRONCHOSPASM 8 0.0006
589 METASTASIS 4 0.0006
590 BLOOD BILIRUBIN INCREASED 15 0.0006
591 OROPHARYNGEAL DISCOMFORT 5 0.0006
592 DERMATITIS BULLOUS 4 0.0006
593 MUSCLE ATROPHY 7 0.0006
594 LIVER FUNCTION TEST ABNORMAL 16 0.0005
595 WOUND INFECTION 6 0.0005
596 ASPIRATION 6 0.0005
597 HYPOPHAGIA 14 0.0005
598 SKIN ULCER 14 0.0005
599 PULMONARY OEDEMA 24 0.0005
600 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
601 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
602 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
603 FRACTURE 10 0.0005
604 ELECTROCARDIOGRAM QT PROLONGED 19 0.0005
605 URINARY TRACT INFECTION 90 0.0005
606 MYOCARDIAL ISCHAEMIA 6 0.0005
607 ACIDOSIS 4 0.0005
608 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
609 ORTHOSTATIC HYPOTENSION 9 0.0005
610 PULMONARY HAEMORRHAGE 4 0.0005
611 HYPOXIA 18 0.0005
612 GASTROINTESTINAL INFLAMMATION 4 0.0005
613 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
614 BLOOD IRON DECREASED 6 0.0005
615 HEAD INJURY 16 0.0005
616 ALANINE AMINOTRANSFERASE INCREASED 31 0.0005
617 BLOOD ALBUMIN DECREASED 4 0.0005
618 BLADDER DISORDER 5 0.0005
619 CARDIO-RESPIRATORY ARREST 21 0.0005
620 HYPERLIPIDAEMIA 6 0.0005
621 WOUND 14 0.0005
622 HYPOTONIA 5 0.0005
623 METABOLIC ACIDOSIS 16 0.0005
624 BLOOD TEST ABNORMAL 7 0.0005
625 BLINDNESS UNILATERAL 7 0.0005
626 MUSCLE TIGHTNESS 8 0.0005
627 RENAL DISORDER 23 0.0005
628 POST PROCEDURAL INFECTION 4 0.0005
629 DECUBITUS ULCER 4 0.0005
630 COVID-19 86 0.0005
631 ASPHYXIA 4 0.0005
632 PARALYSIS 7 0.0005
633 ABNORMAL FAECES 4 0.0005
634 CHROMATURIA 11 0.0005
635 BLOOD GLUCOSE ABNORMAL 9 0.0005
636 DYSPNOEA 274 0.0005
637 GENERALISED TONIC-CLONIC SEIZURE 8 0.0005
638 SECOND PRIMARY MALIGNANCY 4 0.0005
639 EOSINOPHIL COUNT INCREASED 4 0.0005
640 SHOCK 11 0.0005
641 CELLULITIS 24 0.0005
642 COLITIS 18 0.0005
643 FACE OEDEMA 8 0.0005
644 HALLUCINATION, VISUAL 10 0.0005
645 DIVERTICULITIS 13 0.0005
646 CHOLESTASIS 9 0.0005
647 LIVER FUNCTION TEST INCREASED 10 0.0005
648 ANAPHYLACTIC SHOCK 12 0.0005
649 DECREASED ACTIVITY 5 0.0005
650 PYREXIA 160 0.0005
651 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
652 RESPIRATORY TRACT INFECTION 12 0.0005
653 PLATELET COUNT INCREASED 6 0.0005
654 OESOPHAGITIS 5 0.0005
655 BEDRIDDEN 6 0.0005
656 HYPOGLYCAEMIA 22 0.0005
657 ACUTE MYELOID LEUKAEMIA 7 0.0004
658 PERIPHERAL SWELLING 69 0.0004
659 DYSPEPSIA 44 0.0004
660 MALNUTRITION 5 0.0004
661 INTESTINAL PERFORATION 5 0.0004
662 ANAL INCONTINENCE 4 0.0004
663 PALPITATIONS 52 0.0004
664 CARDIAC ARREST 36 0.0004
665 NEUTROPENIA 59 0.0004
666 BLOOD POTASSIUM DECREASED 13 0.0004
667 RHABDOMYOLYSIS 18 0.0004
668 HEPATIC FAILURE 13 0.0004
669 APPENDICITIS 4 0.0004
670 DIARRHOEA HAEMORRHAGIC 4 0.0004
671 EPILEPSY 13 0.0004
672 HEPATOCELLULAR INJURY 6 0.0004
673 FEELING JITTERY 8 0.0004
674 ACCIDENT 5 0.0004
675 HERPES ZOSTER 24 0.0004
676 PERICARDITIS 7 0.0004
677 HYPERCHOLESTEROLAEMIA 4 0.0004
678 ATELECTASIS 4 0.0004
679 HYPOKINESIA 6 0.0004
680 CONSTIPATION 90 0.0004
681 FEELING HOT 25 0.0004
682 DYSURIA 15 0.0004
683 WHITE BLOOD CELL COUNT DECREASED 44 0.0004
684 HYPERCALCAEMIA 5 0.0004
685 RASH MACULO-PAPULAR 9 0.0004
686 DISORIENTATION 16 0.0004
687 NEOPLASM PROGRESSION 14 0.0004
688 SKIN LESION 11 0.0004
689 SECRETION DISCHARGE 5 0.0004
690 DIZZINESS 199 0.0004
691 ASTHENIA 150 0.0004
692 HEART RATE IRREGULAR 9 0.0004
693 INTESTINAL OBSTRUCTION 15 0.0004
694 FEEDING DISORDER 8 0.0004
695 TACHYCARDIA 35 0.0004
696 DRUG LEVEL DECREASED 4 0.0004
697 GAIT DISTURBANCE 75 0.0004
698 ERECTILE DYSFUNCTION 10 0.0004
699 FLATULENCE 22 0.0004
700 TENDONITIS 6 0.0004
701 HYPERTENSION 82 0.0004
702 POOR VENOUS ACCESS 4 0.0004
703 HYPERGLYCAEMIA 14 0.0004
704 SPEECH DISORDER 20 0.0004
705 DYSPHAGIA 36 0.0004
706 ABSCESS 6 0.0004
707 OXYGEN SATURATION DECREASED 21 0.0004
708 MALIGNANT MELANOMA 5 0.0004
709 MALAISE 163 0.0004
710 MUSCULAR WEAKNESS 42 0.0004
711 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
712 OFF LABEL USE 323 0.0004
713 SKIN LACERATION 4 0.0004
714 TACHYPNOEA 5 0.0004
715 MYOCARDIAL INFARCTION 64 0.0004
716 THROMBOCYTOPENIA 41 0.0004
717 SYSTEMIC LUPUS ERYTHEMATOSUS 13 0.0004
718 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
719 TREATMENT NONCOMPLIANCE 20 0.0004
720 COGNITIVE DISORDER 17 0.0004
721 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
722 ABDOMINAL PAIN 84 0.0004
723 TRANSAMINASES INCREASED 8 0.0004
724 DEMENTIA 10 0.0004
725 BACK PAIN 83 0.0004
726 VISUAL IMPAIRMENT 44 0.0004
727 BLOOD PRESSURE ABNORMAL 7 0.0004
728 HEPATIC ENZYME INCREASED 24 0.0004
729 ABDOMINAL DISCOMFORT 59 0.0004
730 PARANOIA 6 0.0003
731 PANCREATIC CARCINOMA 10 0.0003
732 VAGINAL HAEMORRHAGE 15 0.0003
733 CHEST PAIN 64 0.0003
734 DYSARTHRIA 13 0.0003
735 HALLUCINATION 26 0.0003
736 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
737 RASH MACULAR 12 0.0003
738 COLD SWEAT 6 0.0003
739 SLEEP DISORDER 24 0.0003
740 HEAD DISCOMFORT 6 0.0003
741 CARDIOMYOPATHY 5 0.0003
742 PERITONITIS 7 0.0003
743 ABDOMINAL DISTENSION 35 0.0003
744 OSTEONECROSIS 11 0.0003
745 DIARRHOEA 216 0.0003
746 STAPHYLOCOCCAL INFECTION 11 0.0003
747 BLOOD PRESSURE FLUCTUATION 8 0.0003
748 FREQUENT BOWEL MOVEMENTS 9 0.0003
749 INFECTION 48 0.0003
750 LOCALISED INFECTION 8 0.0003
751 BURSITIS 4 0.0003
752 NEOPLASM MALIGNANT 22 0.0003
753 INFLAMMATION 17 0.0003
754 CHRONIC KIDNEY DISEASE 25 0.0003
755 HIP ARTHROPLASTY 5 0.0003
756 RHINORRHOEA 21 0.0003
757 MYALGIA 55 0.0003
758 FEELING COLD 9 0.0003
759 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
760 VOMITING 150 0.0003
761 CYANOSIS 5 0.0003
762 HEPATOTOXICITY 7 0.0003
763 OBESITY 5 0.0003
764 HEART RATE DECREASED 11 0.0003
765 HEPATITIS 8 0.0003
766 CHEST DISCOMFORT 32 0.0003
767 NAUSEA 247 0.0003
768 ACUTE RESPIRATORY FAILURE 6 0.0003
769 SENSORY DISTURBANCE 5 0.0003
770 DIPLOPIA 8 0.0003
771 URINARY INCONTINENCE 9 0.0003
772 SARS-COV-2 TEST POSITIVE 4 0.0003
773 PHOTOSENSITIVITY REACTION 5 0.0003
774 DRUG LEVEL INCREASED 5 0.0003
775 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 61 0.0003
776 CONFUSIONAL STATE 48 0.0003
777 WEIGHT DECREASED 82 0.0003
778 PRODUCTIVE COUGH 14 0.0003
779 SCAR 5 0.0003
780 LUNG NEOPLASM MALIGNANT 12 0.0003
781 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
782 INFUSION RELATED REACTION 19 0.0003
783 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
784 EOSINOPHILIA 5 0.0003
785 SKIN REACTION 4 0.0003
786 LYMPHADENOPATHY 10 0.0003
787 PAIN IN JAW 8 0.0003
788 BLOOD PRESSURE INCREASED 43 0.0003
789 RASH 122 0.0003
790 HOSPITALISATION 43 0.0003
791 LACTIC ACIDOSIS 9 0.0003
792 ERYTHEMA 57 0.0003
793 TREMOR 46 0.0003
794 PRODUCT DISPENSING ERROR 6 0.0003
795 DIABETES MELLITUS 21 0.0003
796 FLUID RETENTION 14 0.0003
797 BONE PAIN 16 0.0003
798 LABORATORY TEST ABNORMAL 8 0.0003
799 GAIT INABILITY 9 0.0003
800 PULMONARY MASS 4 0.0003
801 NECK PAIN 15 0.0003
802 THERAPY NON-RESPONDER 12 0.0003
803 BALANCE DISORDER 23 0.0003
804 ABDOMINAL PAIN UPPER 54 0.0003
805 COUGH 73 0.0003
806 JAUNDICE 7 0.0003
807 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
808 NO ADVERSE EVENT 47 0.0003
809 HERNIA 5 0.0003
810 GASTROINTESTINAL DISORDER 23 0.0003
811 ANAPHYLACTIC REACTION 14 0.0003
812 MENTAL DISORDER 11 0.0003
813 HEART RATE INCREASED 25 0.0003
814 CYSTITIS 8 0.0003
815 RASH ERYTHEMATOUS 12 0.0003
816 FATIGUE 195 0.0003
817 DIABETIC KETOACIDOSIS 6 0.0002
818 INCORRECT DOSE ADMINISTERED 57 0.0002
819 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 45 0.0002
820 MOVEMENT DISORDER 8 0.0002
821 ANGIOEDEMA 11 0.0002
822 SOMNOLENCE 50 0.0002
823 FULL BLOOD COUNT DECREASED 5 0.0002
824 PRURITUS 94 0.0002
825 PAIN IN EXTREMITY 72 0.0002
826 VISUAL ACUITY REDUCED 8 0.0002
827 AGEUSIA 6 0.0002
828 HYPOAESTHESIA 36 0.0002
829 LIP SWELLING 8 0.0002
830 DERMATITIS 5 0.0002
831 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
832 PROSTATE CANCER 19 0.0002
833 EATING DISORDER 5 0.0002
834 PRODUCT USE ISSUE 44 0.0002
835 UNRESPONSIVE TO STIMULI 6 0.0002
836 SKIN CANCER 5 0.0002
837 ARTHRALGIA 96 0.0002
838 PLASMA CELL MYELOMA 9 0.0002
839 BRONCHITIS 17 0.0002
840 PRODUCT PRESCRIBING ISSUE 5 0.0002
841 DEAFNESS 6 0.0002
842 MUCOSAL INFLAMMATION 6 0.0002
843 NEUROTOXICITY 4 0.0002
844 LIMB DISCOMFORT 7 0.0002
845 LUNG DISORDER 11 0.0002
846 CONDITION AGGRAVATED 68 0.0002
847 ORAL PAIN 5 0.0002
848 DISTURBANCE IN ATTENTION 12 0.0002
849 PANCREATITIS ACUTE 5 0.0002
850 DRY MOUTH 18 0.0002
851 DYSKINESIA 9 0.0002
852 LIMB INJURY 6 0.0002
853 SEIZURE 25 0.0002
854 MENTAL STATUS CHANGES 6 0.0002
855 HEADACHE 135 0.0002
856 HEPATIC STEATOSIS 4 0.0002
857 MIDDLE INSOMNIA 4 0.0002
858 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
859 DISEASE PROGRESSION 25 0.0002
860 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
861 DISEASE RECURRENCE 10 0.0002
862 MUSCULOSKELETAL PAIN 11 0.0002
863 PULMONARY FIBROSIS 4 0.0002
864 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
865 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
866 MENTAL IMPAIRMENT 5 0.0002
867 LIVER INJURY 5 0.0002
868 RENAL INJURY 6 0.0002
869 CATARACT 12 0.0002
870 COLITIS ULCERATIVE 9 0.0002
871 SPINAL FRACTURE 4 0.0002
872 THERAPEUTIC RESPONSE DECREASED 12 0.0002
873 BONE MARROW FAILURE 4 0.0002
874 MOBILITY DECREASED 14 0.0002
875 OSTEOPOROSIS 8 0.0002
876 MYELOSUPPRESSION 7 0.0002
877 NERVOUS SYSTEM DISORDER 6 0.0002
878 SWOLLEN TONGUE 6 0.0002
879 OCULAR HYPERAEMIA 9 0.0002
880 NEUROPATHY PERIPHERAL 18 0.0002
881 NIGHT SWEATS 6 0.0002
882 MOOD ALTERED 5 0.0002
883 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
884 CARDIAC DISORDER 17 0.0002
885 VIRAL INFECTION 6 0.0002
886 MEDICATION ERROR 10 0.0002
887 PRODUCT AVAILABILITY ISSUE 4 0.0002
888 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
889 NIGHTMARE 6 0.0002
890 HOT FLUSH 13 0.0002
891 TOXICITY TO VARIOUS AGENTS 29 0.0002
892 DYSSTASIA 5 0.0002
893 CHILLS 20 0.0002
894 PANCREATITIS 9 0.0002
895 DEPRESSED MOOD 9 0.0002
896 DEATH 146 0.0002
897 RESPIRATORY DISORDER 5 0.0002
898 NEURALGIA 4 0.0002
899 ACCIDENTAL OVERDOSE 6 0.0002
900 ENCEPHALOPATHY 4 0.0002
901 DYSGEUSIA 12 0.0002
902 URTICARIA 27 0.0002
903 PARAESTHESIA 25 0.0002
904 ABDOMINAL PAIN LOWER 4 0.0002
905 MUSCLE SPASMS 29 0.0002
906 OVERDOSE 34 0.0002
907 DYSPHONIA 9 0.0002
908 INFLUENZA 17 0.0002
909 NASOPHARYNGITIS 28 0.0002
910 INSOMNIA 40 0.0002
911 RASH PRURITIC 8 0.0001
912 WEIGHT INCREASED 33 0.0001
913 RESPIRATORY ARREST 4 0.0001
914 PROCEDURAL PAIN 4 0.0001
915 ARTHROPATHY 8 0.0001
916 INTENTIONAL DOSE OMISSION 4 0.0001
917 MEMORY IMPAIRMENT 19 0.0001
918 SURGERY 8 0.0001
919 THERAPY CESSATION 7 0.0001
920 OESOPHAGEAL CARCINOMA 4 0.0001
921 UNEVALUABLE EVENT 10 0.0001
922 HYPERHIDROSIS 17 0.0001
923 TINNITUS 6 0.0001
924 DRUG ADMINISTRATION ERROR 4 0.0001
925 BONE DENSITY DECREASED 4 0.0001
926 ALOPECIA 25 0.0001
927 BLISTER 7 0.0001
928 HIP FRACTURE 4 0.0001
929 EYE PAIN 7 0.0001
930 VISION BLURRED 17 0.0001
931 AMNESIA 8 0.0001
932 SWELLING FACE 8 0.0001
933 CHOLELITHIASIS 4 0.0001
934 PRODUCT USE IN UNAPPROVED INDICATION 30 0.0001
935 FUNGAL INFECTION 4 0.0001
936 BLADDER CANCER 7 0.0001
937 SUICIDE ATTEMPT 7 0.0001
938 DEVICE DISLOCATION 5 0.0001
939 ARTHRITIS 9 0.0001
940 BURNING SENSATION 8 0.0001
941 DRUG INTOLERANCE 11 0.0001
942 BLOOD GLUCOSE INCREASED 21 0.0001
943 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
944 THROAT IRRITATION 5 0.0001
945 INTENTIONAL OVERDOSE 7 0.0001
946 SKIN DISCOLOURATION 5 0.0001
947 ADVERSE EVENT 10 0.0001
948 OROPHARYNGEAL PAIN 10 0.0001
949 PRODUCT DOSE OMISSION 7 0.0001
950 ASTHMA 12 0.0001
951 DEPRESSION 24 0.0001
952 INTENTIONAL PRODUCT MISUSE 9 0.0001
953 PAIN 62 0.0001
954 FEELING ABNORMAL 24 0.0001
955 IRRITABILITY 6 0.0001
956 EXTRA DOSE ADMINISTERED 4 0.0001
957 DISCOMFORT 6 0.0001
958 SINUSITIS 10 0.0001
959 HYPERSENSITIVITY 18 0.0001
960 BREAST CANCER 9 0.0001
961 ROAD TRAFFIC ACCIDENT 4 0.0001
962 HYPOACUSIS 4 0.0001
963 MUSCULOSKELETAL STIFFNESS 8 0.0001
964 JOINT SWELLING 11 0.0001
965 FLUSHING 9 0.0001
966 INJECTION SITE HAEMORRHAGE 7 0.0001
967 PRODUCT SUBSTITUTION ISSUE 5 0.0001
968 INJURY 6 0.0001
969 ANXIETY 24 0.0001
970 WHEEZING 5 0.0001
971 PSORIASIS 11 0.0001
972 DRUG INEFFECTIVE 111 0.0001
973 COMA 4 0.0001
974 ILL-DEFINED DISORDER 5 0.0001
975 PRODUCT DOSE OMISSION ISSUE 24 0.0001
976 ADVERSE DRUG REACTION 7 0.0001
977 DRY SKIN 10 0.0001
978 EMOTIONAL DISTRESS 9 0.0001
979 DRUG ABUSE 6 0.0001
980 THERAPY INTERRUPTED 5 0.0001
981 LETHARGY 4 0.0001
982 NASAL CONGESTION 4 0.0001
983 SKIN EXFOLIATION 5 0.0001
984 ILLNESS 6 0.0001
985 INJECTION SITE REACTION 4 0.0001
986 SUICIDAL IDEATION 5 0.0001
987 AGITATION 4 0.0001
988 MIGRAINE 5 0.0001
989 TREATMENT FAILURE 4 0.0000
990 RHEUMATOID ARTHRITIS 5 0.0000
991 DRUG DOSE OMISSION 7 0.0000
992 INJECTION SITE ERYTHEMA 5 0.0000
993 INJECTION SITE PAIN 11 0.0000
994 DRUG DEPENDENCE 4 0.0000